News
July 15, 2019•News
Money in Aging Research, Part II
We need to start with Josh Mittledorf, evolutionary biologist and aging expert, reviews the current state of money in aging research and gives AHNP (now Apollo Health) high marks. Read more … Read More »
May 3, 2019•Interviews, News
Therapy Gives New Hope For Patients with Alzheimer’s Disease
Dr. Dale Bredesen is interviewed by Juliette Goodrich CBS KPIX5 News upon the release of his study “Reversal of Cognitive Decline: 100 Patients.” Read More »
April 21, 2019•Interviews, News
CBN News’ Pat Robertson Talks with Dr. Dale Bredesen
Dr. Dale Bredesen reviews his study “Reversal of Cognitive Decline: 100 Patients,” with CBN News’ Pat Robertson. Read More »
March 4, 2019•News, Press Releases
LifeSeasons is proud to introduce ReCODE Protocol, a new line of cognitive support supplements formulated with the world-renowned neurologist and author of the New York Times bestseller, The End of Alzheimer’s, Dale Bredesen, MD. Read More »
July 26, 2018•News, Press Releases
AHNP Precision Health Launches the ReCODE Report®
Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of The Bredesen Protocol, AHNP Precision Health has launched the US version of the ReCODE Report, a proprietary implementation of the Bredesen Protocol which allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Read More »
July 16, 2018•Interviews, News
Interview with Dr. Dale Bredesen on ABC 7 News about reversing early Alzheimer’s symptoms
Bredesen told ABC7 during an in-studio interview, ‘If it’s in your family, you want to come in, in your 40’s and say, ‘where do we stand?’ We want everyone to get on prevention. We really can reduce the global burden of dementia if we do that.’ Read More »
July 6, 2018•News, Press Releases
AHNP Precision Health Acquires MPI Cognition Dementia Business
AHNP Precision Health is announcing its acquisition of the MPI Cognition dementia business in order to rapidly bring a ground-breaking Alzheimer’s treatment protocol designed by the leading Alzheimer’s researcher to the market. Dale Bredesen MD, Founder, Co-Chairman, and Chief Science Officer of MPI Cognition is the best-selling author of the highly-acclaimed book, The End of Alzheimer’s. Read More »